Vancouver, Canada

Jeffrey Ostrove

This inventor holds 1 USPTO granted patent. Top assignee: Medigene, Inc.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Ostrove. Retrieved from https://idiyas.com/inventor/jeffrey-ostrove

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jeffrey Ostrove

Introduction

Jeffrey Ostrove is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of artificial chromosome constructs. His work has implications for therapeutic applications and recombinant virus production.

Latest Patents

Ostrove holds a patent for "Artificial chromosome constructs containing foreign nucleic acid sequences." This invention provides artificial chromosome constructs that include foreign nucleic acid sequences, such as viral nucleic acid sequences. The methods associated with these constructs are aimed at enhancing therapy and facilitating recombinant virus production.

Career Highlights

Jeffrey Ostrove is currently associated with Medigene, Inc., a company focused on innovative therapies in the field of immunotherapy. His expertise in biotechnology has positioned him as a valuable asset in the research and development of advanced medical solutions.

Collaborations

Ostrove has collaborated with notable colleagues, including Brian Horsburgh and Dong Qiang. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Jeffrey Ostrove's work in artificial chromosome constructs exemplifies the innovative spirit of modern biotechnology. His contributions continue to influence therapeutic strategies and the development of recombinant viruses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…